Acute Injection of IL-6, but not Hepcidin, Results in Hypozincemia but Does not Inhibit Dietary Zinc Absorption in Mice
The Journal of Nutrition · 2026
DOI: 10.1016/j.tjnut.2025.10.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Nutrition, 2026. Verfasst von Stephen R Hennigar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Micronutrient Metabolism Lab, Pennington Biomedical Research Center, Baton Rouge, LA, United States. Electronic address: stephen.hennigar@pbrc.edu. Hauptthemen laut MEDLINE: Hepcidins, Interleukin-6, Zinc, Intestinal Absorption. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Medical Research and Materiel Command.
Abstract (Originalsprache)
BACKGROUND: The iron regulatory hormone hepcidin has been shown to attenuate zinc efflux in human intestinal Caco-2 cells; however, its role in regulating intestinal zinc absorption in vivo remains unclear. OBJECTIVES: The objective of this study was to determine the effects of hepcidin, and its upstream regulator IL-6, on intestinal zinc absorption in mice. METHODS: Six-week-old C57BL/6 mice were fed a modified AIN-93G diet containing 30 ppm zinc and 10 ppm iron for 2 wk. After the run-in diet, mice were intraperitoneally injected with saline or physiologically relevant doses of IL-6 or hepcidin peptide (n = 18/treatment). Immediately after injection, mice were given an oral gavage containing 67Zn. Tissues were collected 3, 6, and 24 h later. Dietary zinc absorption was assessed by measuring 67Zn appearance in plasma and liver by inductively coupled plasma mass spectrometry. Two-way analysis of variance with Tukey's post-hoc comparisons were used to assess the effects of dose within a treatment (hepcidin or IL-6), time, and their interaction. RESULTS: Both IL-6 and hepcidin reduced plasma iron concentrations by ∼25% (P < 0.05). IL-6 (P = 0.03), but not hepcidin (P = 0.37), induced hypozincemia. Neither IL-6 nor hepcidin inhibited the appearance of 67Zn in plasma or liver of mice. CONCLUSIONS: Findings from this in vivo study demonstrate that acute increases in IL-6, but not hepcidin, contribute to the hypozincemia observed with inflammatory and infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Micronutrient Metabolism Lab, Pennington Biomedical Research Center, Baton Rouge, LA, United States. Electronic address: stephen.hennigar@pbrc.edu.
- Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL, United States.
- Military Nutrition Division, US Army Research Institute of Environmental Medicine (USARIEM), Natick, MA, United States.
Förderung
- Medical Research and Materiel Command
Zitieren
APA
Hennigar, S. R., Schairer, J. A., Kelley, A. M., & McClung, J. P. (2026). Acute Injection of IL-6, but not Hepcidin, Results in Hypozincemia but Does not Inhibit Dietary Zinc Absorption in Mice. The Journal of Nutrition. https://doi.org/10.1016/j.tjnut.2025.10.034
Vancouver
Hennigar SR, Schairer JA, Kelley AM, McClung JP. Acute Injection of IL-6, but not Hepcidin, Results in Hypozincemia but Does not Inhibit Dietary Zinc Absorption in Mice. The Journal of Nutrition. 2026. doi:10.1016/j.tjnut.2025.10.034
BibTeX
@article{Hennigar2026,
author = {Hennigar, Stephen R and Schairer, James A and Kelley, Alyssa M and McClung, James P},
title = {Acute Injection of IL-6, but not Hepcidin, Results in Hypozincemia but Does not Inhibit Dietary Zinc Absorption in Mice},
journal = {The Journal of Nutrition},
year = {2026},
doi = {10.1016/j.tjnut.2025.10.034}
}
EUVIMED